Dalphene Labs
Clinical studies and technique, read for the operator. The flagship.
Research, page 4
1234Back to page 1 →Research
FDA approves eight week maintenance dosing for Ebglyss in atopic dermatitis
Lebrikizumab (Ebglyss) Gets FDA Nod for Reduced Every-8-Week Maintenance Dosing

Research
Microfocused ultrasound plus microneedle RF, head to head on the same face
A 26-patient split-face trial shows where stacking two devices actually pays off.

Research
Doubling your PDO thread count does not double the lift
A randomized trial of 3 versus 6 threads per hemiface, measured by 3D imaging.

Research
You may not need to customize glabellar injection points to contraction pattern
A 42-patient review tests whether the patient's frown pattern predicts the result.

Research
Masseter slimming peaks at 12 weeks, and chewing holds steady
A 24-patient prospective study tracks both jawline volume and bite function.

Research
Conexeu Completes Preclinical Study for New Collagen Volume Restoration Platform
Conexeu Sciences Concludes Preclinical Study for Regenerative Collagen Aesthetic Platform

Research
A two-plane tear-trough technique matched to filler stiffness
A small case series layers high- and low-G-prime fillers to cut lumpiness and Tyndall.

Research
Cold-Crosslinked HA Held Nasolabial Correction Better Than Restylane-L at 6 and 12 Months
A split-face RCT against Restylane-L in the nasolabial fold, read out to 12 months.

Research
PLLA vs CaHA: A Durability Gap of Roughly Two Years vs One
A PRISMA review of 14 studies puts numbers on the durability difference between the two biostimulators.

Research
Skinvive Added to Crow's-Feet Botox Improved the Lines the Toxin Missed
A split-face crow's-feet RCT tested whether an HA booster adds anything to toxin. It does, just not where you would expect.

Research
Under-Eye Rejuvenation: When Polynucleotides Beat Reflexive HA Filler
A narrative review on choosing between volume and skin quality in the high-risk periorbital zone.

Research
Polynucleotides vs HA filler for the under-eye, reviewed
An evidence review lands on case selection, not a winner.